These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38843423)

  • 1. Cost-Effectiveness Analysis of Remimazolam and Midazolam in Goal-Guided Sedation in ICU.
    Yang F; Yi S; Xing J; Sun L; Liu L; Cao B; Bao Y
    Altern Ther Health Med; 2024 Jun; ():. PubMed ID: 38843423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remimazolam tosylate's long-term sedative properties in ICU patients on mechanical ventilation: effectiveness and safety.
    Yao Z; Liao Z; Li G; Wang L; Zhan L; Xia W
    Eur J Med Res; 2023 Oct; 28(1):452. PubMed ID: 37865799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of using dexmedetomidine in ventilator bundle treatment in an ICU].
    Song R; Li J; Dong C; Yang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Oct; 27(10):836-40. PubMed ID: 27132448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bolus administration of remimazolam was superior to midazolam for deep sedation in elderly patients undergoing diagnostic bronchoscopy: A randomized, double-blind, controlled trial.
    Wu Q; Xu R; Zhou X; Wang L; Sheng C; Ding M; Cao Y
    Medicine (Baltimore); 2024 Mar; 103(12):e37215. PubMed ID: 38518001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of remimazolam for procedural sedation during ultrasound-guided transversus abdominis plane block and rectus sheath block in patients undergoing abdominal tumor surgery: a single-center randomized controlled trial.
    Xiao Y; Wei R; Chen L; Chen Y; Kong L
    BMC Anesthesiol; 2022 Dec; 22(1):381. PubMed ID: 36476171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of Sedation With Remimazolam Compared to Midazolam for the Removal of Impacted Tooth in Patients With Dental Anxiety.
    Li X; Tian M; Deng Y; She T; Li K
    J Oral Maxillofac Surg; 2023 May; 81(5):536-545. PubMed ID: 36852757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Remimazolam Tosilate Combined With Esketamine for Analgesic Sedation in Mechanically Ventilated ICU Patients: A Single-Arm Clinical Study Protocol.
    Song X; Wang F; Dong R; Zhu K; Wang C
    Front Med (Lausanne); 2022; 9():832105. PubMed ID: 35372406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine use in the ICU: are we there yet?
    Ahmed S; Murugan R
    Crit Care; 2013 May; 17(3):320. PubMed ID: 23731973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.
    Barrientos-Vega R; Mar Sánchez-Soria M; Morales-García C; Robas-Gómez A; Cuena-Boy R; Ayensa-Rincon A
    Crit Care Med; 1997 Jan; 25(1):33-40. PubMed ID: 8989173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of remimazolam versus midazolam for procedural sedation: post hoc integrated analyses of three phase 3 clinical trials.
    Dao VA; Schippers F; Stöhr T
    Endosc Int Open; 2022 Apr; 10(4):E378-E385. PubMed ID: 35433203
    [No Abstract]   [Full Text] [Related]  

  • 12. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
    Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
    Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of remimazolam and dexmedetomidine for intraoperative sedation in patients undergoing lower extremity surgery under spinal anesthesia: a randomized clinical trial.
    Kim H; Kim Y; Bae J; Yoo S; Lim YJ; Kim JT
    Reg Anesth Pain Med; 2024 Feb; 49(2):110-116. PubMed ID: 37280081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of remimazolam-based sedation for intensive care unit patients undergoing upper gastrointestinal endoscopy: a cohort study.
    Zhao YR; Huang KS; Hou G; Yao L; Lu LP; Xu S; Lian YT; Yao Z; Yu Z
    World J Emerg Med; 2023; 14(1):31-36. PubMed ID: 36713335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of dexmedetomidine and midazolam for monitored anesthesia care combined with tramadol via patient-controlled analgesia in endoscopic nasal surgery: A prospective, randomized, double-blind, clinical study.
    Karaaslan K; Yilmaz F; Gulcu N; Colak C; Sereflican M; Kocoglu H
    Curr Ther Res Clin Exp; 2007 Mar; 68(2):69-81. PubMed ID: 24678121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexmedetomidine versus midazolam for the sedation of patients with non-invasive ventilation failure.
    Huang Z; Chen YS; Yang ZL; Liu JY
    Intern Med; 2012; 51(17):2299-305. PubMed ID: 22975538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam and propofol used alone or sequentially for long-term sedation in critically ill, mechanically ventilated patients: a prospective, randomized study.
    Zhou Y; Jin X; Kang Y; Liang G; Liu T; Deng N
    Crit Care; 2014 Jun; 18(3):R122. PubMed ID: 24935517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.
    Morimoto Y
    Ther Clin Risk Manag; 2022; 18():95-100. PubMed ID: 35140469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.